Oxysphair SRL
31.1 FTEOxysphair reported revenue of €15.9m for the 2025 financial year (annual accounts filed with the NBB on 18 Jun 2026), with 31.1 full-time equivalents.
The score of Oxysphair shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +46 % Equity +27 % Total assets +32 % Headcount (avg FTE) +11 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Oxysphair's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €15.9m | ||||
| Net result | €1.96m | ||||
| Equity | €4.92m | ||||
| Cash | €1.06m | ||||
| EBITDA | €4.02m | ||||
| Total assets | €9.79m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 18 Jun 2026
- Year ended 31 Dec 2024filed on 07 Jul 2025
- Year ended 31 Dec 2023filed on 18 Jun 2024
- Year ended 31 Dec 2022filed on 26 Jun 2023
- Year ended 31 Dec 2021filed on 27 Jun 2022
Oxysphair's financial analysis
- Solvency50.3%sector median: 43.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Oxysphair
Oxysphair's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0466.323.738
- VAT number
- BE0466323738
- Peppol
- Registered · 0208:0466323738 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 Jun 1999
- Registered office
- 6180 Courcelles
- Size
- Small · 31.1 FTE
- Latest accounts
- 2025 · filed on 18 Jun 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Oxysphair (SRL) has been based in Courcelles since 1999, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of €15.9m, a net profit of €1.96m and equity of €4.92m. With 31.1 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 50.3%, above the median of its sector (43.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Oxysphair
Companies in the same business, of comparable size and area, outside its group.
- Alexion Pharma Belgium Manufacture of pharmaceutical preparations Brussels · balance sheet €8.68m
- Canon Medical Systems Belgium Manufacture of medical and dental instruments and supplies Zaventem · balance sheet €9.24m
- Andocor Manufacture of medical and dental instruments and supplies Hoogstraten · balance sheet €12.3m
- VIGO Manufacture of medical and dental instruments and supplies Wetteren · balance sheet €68.1m
- Innomediq Wholesale of pharmaceutical and medical goods Heist-op-den-Berg · balance sheet €12.3m
- International Medical Products Wholesale of pharmaceutical and medical goods Saint-Gilles · balance sheet €10.2m
Frequently asked questions about Oxysphair
What is the revenue of Oxysphair?
According to the 2025 annual accounts filed with the NBB, the revenue of Oxysphair amounts to 15,885,223 €.
What is the VAT number of Oxysphair?
In Belgium, the VAT number is the company number prefixed with BE: BE0466323738 for Oxysphair, if the company is VAT-registered. Its company number (CBE) is 0466.323.738.
Where is the registered office of Oxysphair?
According to the CBE register, the registered office of Oxysphair is in 6180 Courcelles.
What is the equity of Oxysphair?
At the close of the 2025 financial year, the equity of Oxysphair amounts to 4,921,845 €, a solvency of 50.3% of total assets.
How many people work at Oxysphair?
31.1 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Oxysphair?
The register lists 4 active mandates at Oxysphair. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Oxysphair
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →